Trademark: 87006402
Status Date
Monday, July 23, 2018
Filing Date
Tuesday, April 19, 2016
Published for Opposition
Tuesday, October 25, 2016
Abandoned Date
Monday, July 23, 2018
5 Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
Jul 23, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jul 23, 2018
Abandonment - No Use Statement Filed
Dec 21, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2017
Extension 2 Granted
Dec 19, 2017
Extension 2 Filed
Dec 19, 2017
Teas Extension Received
Dec 19, 2017
Teas Change Of Correspondence Received
Jun 12, 2017
Teas Change Of Correspondence Received
Jun 9, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2017
Extension 1 Granted
Jun 7, 2017
Extension 1 Filed
Jun 7, 2017
Teas Extension Received
Dec 20, 2016
Noa E-Mailed - Sou Required From Applicant
Oct 25, 2016
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2016
Published For Opposition
Oct 5, 2016
Notification Of Notice Of Publication E-Mailed
Sep 19, 2016
Law Office Publication Review Completed
Sep 16, 2016
Approved For Pub - Principal Register
Sep 16, 2016
Teas/Email Correspondence Entered
Sep 16, 2016
Correspondence Received In Law Office
Sep 8, 2016
Assigned To Lie
Aug 30, 2016
Teas Response To Office Action Received
May 24, 2016
Notification Of Non-Final Action E-Mailed
May 24, 2016
Non-Final Action E-Mailed
May 24, 2016
Non-Final Action Written
May 23, 2016
Assigned To Examiner
Apr 25, 2016
New Application Office Supplied Data Entered In Tram
Apr 22, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
